Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
The Prostate|April 8, 2026
Bone Metastasis Distribution Matters: Prognostic Effect of the Axial-to-Peripheral Ratio in Metastatic Hormone-Sensitive Prostate CancerAli Fuat Gürbüz, Murat Araz, Hacer Demir, et al.
Future Oncology (London, England)|September 24, 2024
The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patientsDilek Çağlayan, Mehmet Zahid Koçak, Çağlayan Geredeli, et al.
American Journal of Cancer Research|July 16, 2025
Are they all the same? Different effects of opioid types on survival in metastatic NSCLC receiving nivolumabOnur Yazdan Balçık, İsmail Beypınar, Semiha Urvay, et al.
Medicina (Kaunas, Lithuania)|October 29, 2025
Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with ErlotinibOğuzhan Yıldız, Talat Aykut, Bahattin Engin Kaya, et al.
The Prostate|November 24, 2025
Prognostic Effect of KELIM Score of Prostate-Specific Antigen in Hormone-Sensitive Prostate Cancer Patients Treated With Novel Androgen Receptor Inhibitors: Pioneering New WaysYusuf Ilhan, Murat Araz, Ali Fuat Gurbuz, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 24, 2026
Evaluation of Inflammatory Parameters and Ferritin as Prognostic Factors in Non-small Cell Lung Cancer Patients Receiving Nivolumab Immunotherapyİsmail Beypınar, Onur Yazdan Balçık, Semiha Urvay, et al.
Current Problems in Cancer|August 18, 2020
Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma?Tarık Demir, Altay Aliyev, Mehmet Beşiroğlu, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2018
Regorafenib or rechallenge chemotherapy: which is more effective in the third-line treatment of metastatic colorectal cancer?Osman Köstek, Muhammet Bekir Hacıoğlu, Abdullah Sakin, et al.
Clinical Lung Cancer|June 13, 2024
Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous AdenocarcinomaTarık Demir, Murat Araz, Carolyn Moloney, et al.
The Prostate|February 20, 2025
Prognostic Nutritional Index as a Biomarker in Metastatic Hormone-Sensitive Prostate Cancer: Impact on Survival and Treatment OptimizationMuhammet Bekir Hacioglu, Ahmet Kucukarda, Ivo Gokmen, et al.
Pageof 9